FdaApplication
ANDA 216961
Identifiers
- fda_app_no: ANDA216961
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-10-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| THEOPHYLLINE | THEOPHYLLINE | 300MG | TABLET, EXTENDED RELEASE;ORAL |
| THEOPHYLLINE | THEOPHYLLINE | 450MG | TABLET, EXTENDED RELEASE;ORAL |
2 products